Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.
Cognitive deficits such as impaired decision-making can be a consequence of persistent pain. Normal functions of the intact amygdala and prefrontal cortex are required for emotion-based decision-making that relies on the ability to assess risk, attribute value, and identify advantageous strategies. We tested the hypothesis that pain-related cognitive deficits result from amygdala-driven impairment of medial prefrontal cortical (mPFC) function. To do this, we used electrophysiological single-unit recordings in vivo, patch clamp in brain slices, and various behavioral assays to show that increased neuronal activity in the amygdala in an animal model of arthritis pain was accompanied by decreased mPFC activation and impaired decision-making. Furthermore, pharmacologic inhibition (with a corticotropin-releasing factor 1 receptor antagonist) of pain-related hyperactivity in the basolateral amygdala (BLA), but not central amygdala (CeA), reversed deactivation of mPFC pyramidal cells and improved decision-making deficits. Pain-related cortical deactivation resulted from a shift of balance between inhibitory and excitatory synaptic transmission. Direct excitatory transmission to mPFC pyramidal cells did not change in the pain model, whereas polysynaptic inhibitory transmission increased. GABAergic transmission was reduced by non-NMDA receptor antagonists, suggesting that synaptic inhibition was glutamate driven. The results are consistent with a model of BLA-driven feedforward inhibition of mPFC neurons. In contrast to the differential effects of BLA versus CeA hyperactivity on cortical-cognitive functions, both amygdala nuclei modulate emotional-affective pain behavior. Thus, this study shows that the amygdala contributes not only to emotional-affective but also cognitive effects of pain. The novel amygdalo-cortical pain mechanism has important implications for our understanding of amygdala functions and amygdalo-cortical interactions.
Ji
Guangchen
G
Department of Neuroscience and Cell Biology, The University of Texas Medical Branch, Galveston, Texas 77555-1069, USA.
Sun
Hao
H
Fu
Yu
Y
Li
Zhen
Z
Pais-Vieira
Miguel
M
Galhardo
Vasco
V
Neugebauer
Volker
V
D000679:Amygdala / Q000187:drug effects / Q000503:physiopathology*; D000818:Animals; D001168:Arthritis / Q000150:complications / Q000503:physiopathology; D003072:Cognition Disorders / Q000150:complications / Q000503:physiopathology*; D003657:Decision Making / Q000187:drug effects / Q000502:physiology; D004195:Disease Models, Animal; D066298:In Vitro Techniques; D009433:Neural Inhibition / Q000187:drug effects / Q000502:physiology; D009434:Neural Pathways / Q000187:drug effects / Q000503:physiopathology; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010146:Pain / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000503:physiopathology*; D017966:Pyramidal Cells / Q000187:drug effects / Q000502:physiology; D051381:Rats; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism; D000099052:CRF Receptor, Type 1
D018019:Receptors, Corticotropin-Releasing Hormone; D005680:gamma-Aminobutyric Acid; D000099052:CRF Receptor, Type 1
Annu Rev Neurosci. 2004;27:1-28
15217324
Acta Endocrinol (Copenh). 1983 Apr;102(4):583-8
6303034
J Neurosci. 2006 Aug 9;26(32):8360-7
16899731
Nat Protoc. 2007;2(2):322-8
17406592
Nat Rev Neurosci. 2004 Oct;5(10):793-807
15378039
Mol Pain. 2007 Jun 05;3:13
17550594
J Neurosci. 2007 Feb 14;27(7):1543-51
17301163
Neuron. 2001 May;30(2):619-39
11395019
J Neurosci. 2006 Apr 12;26(15):4063-70
16611823
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2423-8
19171885
Neuron. 2009 Jun 25;62(6):757-71
19555645
Nature. 1999 Nov 18;402(6759):294-6
10580500
Nat Neurosci. 2007 Aug;10(8):949-51
17603478
Neuron. 2008 Jun 12;58(5):662-71
18549779
J Neurophysiol. 2009 Oct;102(4):2253-64
19625541
Trends Neurosci. 2006 May;29(5):272-9
16545468
J Neurosci Methods. 2006 Mar 15;151(2):148-58
16154203
Nature. 2003 Jul 17;424(6946):316-20
12867983
Nat Neurosci. 2009 Jul;12(7):939-45
19503087
Neuron. 2009 Mar 12;61(5):774-85
19285473
J Neurophysiol. 2002 Dec;88(6):3487-97
12466463
Neuroscience. 2006;139(3):1039-48
16527423
J Neurosci. 2004 Apr 7;24(14):3471-9
15071094
Eur J Neurosci. 2003 Oct;18(8):2343-50
14622196
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):18004-9
19815518
Neuron. 2005 Oct 20;48(2):175-87
16242399
Brain Res Rev. 2009 Apr;60(1):226-42
19162070
J Neurophysiol. 1995 Dec;74(6):2329-35
8747195
Nat Rev Neurosci. 2004 Nov;5(11):844-52
15496862
Pain. 2007 Jan;127(1-2):161-72
17055162
Nature. 2006 Jun 15;441(7095):876-9
16778890
J Neurosci. 2008 Apr 9;28(15):3861-76
18400885
Nat Neurosci. 2007 Apr;10(4):462-8
17334362
J Physiol. 2005 May 1;564(Pt 3):907-21
15760935
Neuron. 2007 Apr 5;54(1):51-8
17408577
Brain Res. 1996 May 13;720(1-2):211-9
8782914
Neuroscience. 2008 Aug 26;155(3):573-84
18640246
J Neurosci. 2006 Jun 14;26(24):6458-68
16775133
J Neurosci. 1997 Feb 1;17(3):983-95
8994053
Physiol Rev. 2003 Jul;83(3):803-34
12843409
Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1622-9
17347454
J Neurosci. 2006 Apr 19;26(16):4415-25
16624961
J Neurophysiol. 1999 Jul;82(1):272-82
10400956
Curr Opin Neurobiol. 2004 Apr;14(2):148-55
15082318
J Neurosci. 1995 Dec;15(12):8199-213
8613754
Pain. 2002 Mar;96(1-2):153-62
11932071
Neuroscience. 2006 Sep 29;142(1):1-20
16887277
J Neurosci. 2004 Nov 17;24(46):10410-5
15548656
Endocr Res. 2004 Nov;30(4):661-6
15666809
Annu Rev Pharmacol Toxicol. 1998;38:201-27
9597154
Neuroscientist. 2004 Jun;10(3):221-34
15155061
Mol Pain. 2007 Mar 28;3:8
17391515
J Neurophysiol. 2000 Aug;84(2):759-70
10938303
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8351-6
15928095
Pain. 1992 Jan;48(1):89-99
1738579
J Neurophysiol. 2007 Jun;97(6):3893-904
17392412
Ann N Y Acad Sci. 2003 Apr;985:356-69
12724171
Nature. 2008 Jul 31;454(7204):600-6
18615015
Nat Rev Neurosci. 2009 Jun;10(6):423-33
19469026
J Comp Neurol. 1990 Aug 1;298(1):40-9
1698828
Neuron. 2007 Mar 1;53(5):735-46
17329212
Neuroscience. 1991;44(1):1-14
1722886
J Neurosci. 1999 Jul 1;19(13):5473-81
10377356
Pain. 2004 Mar;108(1-2):129-36
15109516
Neuroscience. 2007 Mar 2;145(1):225-31
17204373
J Neurophysiol. 2003 Feb;89(2):716-27
12574449
Science. 2007 Oct 26;318(5850):602-6
17962553
Biol Psychiatry. 2007 Sep 1;62(5):446-54
17217927
Neuron. 2008 Sep 11;59(5):829-38
18786365
J Neurosci. 2003 Jan 1;23(1):52-63
12514201
J Neurosci. 2009 Jul 15;29(28):8991-5
19605636
Neuroscience. 2007 Sep 7;148(3):737-43
17706366
Neuroscience. 2009 Jul 7;161(3):671-9
19362121
J Neurophysiol. 2001 May;85(5):2213-23
11353036
Genes Brain Behav. 2003 Oct;2(5):295-302
14606694
J Neurosci. 1992 Oct;12(10):4066-79
1403101
Brain Res. 1998 Oct 12;808(1):101-5
9795166
Science. 2007 May 4;316(5825):758-61
17478724